Category: Drug Discovery
Drug Discovery market research reports by Icon Group International, Inc.
-
The 2025-2030 World Outlook for Alpha-1 Antitrypsin Drugs
The 2025-2030 World Outlook for Alpha-1 Antitrypsin Drugs This study covers the world outlook for alpha-1 antitrypsin drugs across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in mill ... Read More
-
The 2025-2030 World Outlook for Dermatology Therapeutics
The 2025-2030 World Outlook for Dermatology Therapeutics This study covers the world outlook for dermatology therapeutics across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millio ... Read More
-
The 2025-2030 World Outlook for Tuberculosis Treatment Drugs
The 2025-2030 World Outlook for Tuberculosis Treatment Drugs This study covers the world outlook for tuberculosis treatment drugs across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (i ... Read More
-
The 2025-2030 World Outlook for Melanoma Diagnostics and Therapeutics
The 2025-2030 World Outlook for Melanoma Diagnostics and Therapeutics This study covers the world outlook for melanoma diagnostics and therapeutics across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the coun ... Read More
-
The 2025-2030 World Outlook for Infectious Disease Therapeutics
The 2025-2030 World Outlook for Infectious Disease Therapeutics This study covers the world outlook for infectious disease therapeutics across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in quest ... Read More
-
The 2025-2030 World Outlook for Anaplastic Thyroid Cancer Drugs
The 2025-2030 World Outlook for Anaplastic Thyroid Cancer Drugs This study covers the world outlook for anaplastic thyroid cancer drugs across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in quest ... Read More
-
The 2025-2030 World Outlook for Prescription Dermatology Therapeutics
The 2025-2030 World Outlook for Prescription Dermatology Therapeutics This study covers the world outlook for prescription dermatology therapeutics across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the coun ... Read More
-
The 2025-2030 World Outlook for Microbiome Therapeutics
The 2025-2030 World Outlook for Microbiome Therapeutics This study covers the world outlook for microbiome therapeutics across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions ... Read More
-
The 2025-2030 World Outlook for Gauchier Diseases
The 2025-2030 World Outlook for Gauchier Diseases This study covers the world outlook for Gauchier diseases across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dol ... Read More
-
The 2025-2030 World Outlook for Vaginitis Therapeutics
The 2025-2030 World Outlook for Vaginitis Therapeutics This study covers the world outlook for vaginitis therapeutics across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions o ... Read More
-
The 2025-2030 World Outlook for Orphan Disease Therapeutics in Genetics Disorders
The 2025-2030 World Outlook for Orphan Disease Therapeutics in Genetics Disorders This study covers the world outlook for orphan disease therapeutics in genetics disorders across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earning ... Read More
-
The 2025-2030 World Outlook for Overactive Bladder Therapeutics
The 2025-2030 World Outlook for Overactive Bladder Therapeutics This study covers the world outlook for overactive bladder therapeutics across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in quest ... Read More
-
The 2025-2030 World Outlook for Orphan Diseases Therapeutics in CNS
The 2025-2030 World Outlook for Orphan Diseases Therapeutics in CNS This study covers the world outlook for orphan diseases therapeutics in CNS across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country ... Read More
-
The 2025-2030 World Outlook for Drug Developments
The 2025-2030 World Outlook for Drug Developments This study covers the world outlook for drug developments across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dol ... Read More
-
The 2025-2030 World Outlook for Drug Discovery Outsourcing
The 2025-2030 World Outlook for Drug Discovery Outsourcing This study covers the world outlook for drug discovery outsourcing across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in mi ... Read More
-
The 2025-2030 World Outlook for Biosimulation Technology Software
The 2025-2030 World Outlook for Biosimulation Technology Software This study covers the world outlook for biosimulation technology software across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in q ... Read More
-
The 2025-2030 World Outlook for Rare Disease Treatments
The 2025-2030 World Outlook for Rare Disease Treatments This study covers the world outlook for rare disease treatments across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions ... Read More
-
The 2025-2030 World Outlook for Peptide Synthesis
The 2025-2030 World Outlook for Peptide Synthesis This study covers the world outlook for peptide synthesis across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dol ... Read More
-
The 2025-2030 World Outlook for Hereditary Angioedema
The 2025-2030 World Outlook for Hereditary Angioedema This study covers the world outlook for hereditary angioedema across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of ... Read More
-
The 2025-2030 World Outlook for Hormone-Drug Breast Cancer Therapeutics
The 2025-2030 World Outlook for Hormone-Drug Breast Cancer Therapeutics This study covers the world outlook for hormone-drug breast cancer therapeutics across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the ... Read More
-
The 2025-2030 World Outlook for Diabetic Retinopathy Therapeutics
The 2025-2030 World Outlook for Diabetic Retinopathy Therapeutics This study covers the world outlook for diabetic retinopathy therapeutics across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in q ... Read More
-
The 2025-2030 World Outlook for Neglected Tropical Disease Treatments
The 2025-2030 World Outlook for Neglected Tropical Disease Treatments This study covers the world outlook for neglected tropical disease treatments across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the coun ... Read More
-
The 2025-2030 World Outlook for Neurodegenerative Diseases Drugs
The 2025-2030 World Outlook for Neurodegenerative Diseases Drugs This study covers the world outlook for neurodegenerative diseases drugs across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in que ... Read More
-
The 2025-2030 World Outlook for Anxiety Disorder Therapeutics
The 2025-2030 World Outlook for Anxiety Disorder Therapeutics This study covers the world outlook for anxiety disorder therapeutics across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question ... Read More
-
The 2025-2030 World Outlook for Next Generation Antibody Therapeutics
The 2025-2030 World Outlook for Next Generation Antibody Therapeutics This study covers the world outlook for next generation antibody therapeutics across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the coun ... Read More
Research Assistance
